Torrent Pharmaceuticals Limited Stock: price and insider trades · India
No insider purchase over the last 90 days. The latest, by Geena Malhotra, was filed 03 Jun 2026.
Torrent Pharmaceuticals Limited: what insiders have been doing
Torrent Pharmaceuticals Limited belongs to the Health Care sector. Filings by its managers are published through SEBI (PIT + SAST). 1 insider has disclosed 4 filings since 23 October 2025.
No insider sold shares on the market over the period. Instead, the filings list 4 purchases totalling €22k, made by 1 insider. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Biggest ticket of the year: €7,238, bought by Geena Malhotra and made public on 1 June 2026.
With 4 filings in twelve months, the company is in line with the median of 4 filings across the 1,892 companies we follow on the same exchange. Over the whole record (from 2021), the tally stands at 8 purchases and no sales.
The last purchase on record was published on 3 June 2026, which is 158 days ago. Most trades are made public on the day they happen. The shorter that gap, the sooner other investors can see what insiders have done.
Other companies in the same sector with recent insider buying flagged by our signals: Dynavox Group AB and EssilorLuxottica. Source: insider filings from SEBI (PIT + SAST). Past trades are no guide to future returns.
Who traded when
BuySaleSince the insiders bought
- +5.1%Entry ₹4,337.65 · Close 19 Oct 2026 ₹4,558.70
- -2.5%Entry ₹1,468.03 · Close at T+365 ₹1,431.32
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate Torrent Pharmaceuticals Limited Buy (bullish), based on 28 analysts. Average price target: ₹5,481.14.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
- 100 shares@ ₹3,943.8016.5% of flowEquity SharesMarket PurchaseSEBI:9ae103aa44fc7a917c781e7ea36ffdb809c7e114Canonical exit: 1 Sept 2026 (T+90)
- 200 shares@ ₹4,003.0033.4% of flowEquity SharesMarket PurchaseSEBI:c548ca26ebfe9c5b68ed249b2487cc1fabf47da7Canonical exit: 1 Sept 2026 (T+90)
- 100 shares@ ₹3,943.8016.5% of flowEquity SharesMarket PurchaseSEBI:06768358d29b23989fa87795897fbb8eb46e6a2eCanonical exit: 30 Aug 2026 (T+90)
- 200 shares@ ₹4,003.0033.6% of flowEquity SharesMarket PurchaseSEBI:077a2a4bcaa82b96de02c48e1b4e921e78eb9562Canonical exit: 30 Aug 2026 (T+90)
- 930,144 sharesEquity SharesSEBI:5726701a77a0127513525595689dad329f3f7ebd
- 3,600 shares@ ₹2,793.9025.1% of flowEquity SharesSEBI:8412b58fda14c1b6208653efd98a37120ee3b48c
- 6,875 shares@ ₹2,899.911750.0% of flowEquity SharesSEBI:455b051747c5416dffd6897248ac06b118af9b5aCanonical exit: 22 Sept 2021 (T+90)
- 1,050 shares@ ₹2,803.83337.3% of flowEquity SharesSEBI:e60660a7bfc210c0c00b874cb6114beb8bfd774dCanonical exit: 31 Aug 2021 (T+90)
- 1,820 shares@ ₹2,750.009912.5% of flowEquity SharesSEBI:ffcff5972d7ae3bc30d050e455ca0dd0e9d7952eCanonical exit: 30 Aug 2021 (T+90)
- 730 shares@ ₹2,736.96715.0% of flowConvertible DebentureSEBI:8f9c77efdc9dd8c8685af2920c21b37d50058b75Canonical exit: 29 Aug 2021 (T+90)
10 of 10 declarations
About Torrent Pharmaceuticals Limited
Torrent Pharmaceuticals Limited is an Indian pharmaceutical company focused on the production of generic drugs and healthcare products. It is listed on the Bombay Stock Exchange.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
